POLY Division Webinar Series
Most recent WEBINAR:
High Impact Nanotechnology Applications of Layer-by-Layer Assemblies
August 10, 2018
In 2018, the ACS Division of Polymer Chemistry is pleased to offer a new free webinar series focused on contemporary topics from recognized leaders in the field. This second webinar will feature two 20-minute presentations regarding layer-by-layer (LbL) nanotechnology regarding nanocoatings with high impact applications and commercial-scale processing as well as LbL drug release systems for regenerative medicine and targeted nanotherapies.
What You Will Learn: * Why Sub-micron, water-based multilayer nanocoatings can impart gas barrier to commodity polymer film (e.g. PET) that rivals metal and metal oxide coatings * How conformal multilayer nanocoatings can impart highly effective flame retardant properties to highly flammable nylon/cotton and polyester/cotton blends using environmentally-benign chemistries and with relatively low weight addition * How Layer-by-layer assembly can be used to deposit functional thin films at high speed using roll-to-roll coating technology * Why LbL is a unique platform for controlled delivery of drugs from a range of different surfaces * How activity of sensitive proteins and nucleic acids can be preserved and released over extended periods at physiologically relevant doses * What are the means of staggering the release of two or more drugs and its resulting efficacy
Jaime Grunlan, Texas A&M University
Jaime Grunlan joined Texas A&M University as an Assistant Professor of Mechanical Engineering in July of 2004, after spending three years at the Avery Research Center in Pasadena, CA. In 2010, he was promoted to Associate Professor and to Professor in 2013. In 2014, he was awarded the Linda & Ralph Schmidt ’68 Professorship in Mechanical Engineering. He holds joint appointments in Materials Science and Engineering and in Chemistry. His current research interests lie in the transport properties (e.g., gas permeability and electrical conductivity) of polymer nanocomposites. In the Polymer NanoComposites Laboratory, his research group is developing gas barrier, flame retardant and thermoelectric nanocoatings (< 1 µm thick) using layer-by-layer assembly. They are also working on polyelectrolyte complexes and the study of electrically conductive and thermoelectric thick film nanocomposites (>10 µm thick). He has now graduated 19 PhD students (as of September 2016) and published more than 110 peer reviewed journal papers. In addition, he is an Editor for Journal of Materials Science, Associate Editor for Green Materials and serve on the International Advisory Board for Macromolecular Rapid Communications and Macromolecular Materials and Engineering.
Paula Hammond, Massachusetts Institute of Technology
Professor Paula T. Hammond is the David H. Koch Chair Professor of Engineering at the Massachusetts Institute of Technology, and the Head of the Department of Chemical Engineering. She is a member of MIT’s Koch Institute for Integrative Cancer Research, the MIT Energy Initiative, and a founding member of the MIT Institute for Soldier Nanotechnology. Her research in nanomedicine encompasses the development of new biomaterials to enable drug delivery from surfaces with spatio-temporal control.She also investigates novel responsive polymer architectures for targeted nanoparticle drug and gene delivery, and has developed self-assembled materials systems for electrochemical energy devices. Professor Paula Hammond was elected into the National Academy of Engineering in 2017. She was elected into the National Academy of Medicine in 2016, and into the 2013 Class of the American Academy of Arts and Sciences. She is also the recipient of the 2013 AIChE CharlesM.A. Stine Award, which is bestowed annually to a leading researcher in recognition of outstanding contributions to the field of materials science and engineering, and the 2014 AIChE Alpha Chi Sigma Award for Chemical Engineering Research. She has designed multilayered nanoparticles to deliver a synergistic combination of siRNA or inhibitors with chemotherapy drugs in a staged manner to tumors, leading to significant decreases in tumor growth and a great lowering of toxicity. Professor Hammond has published over 320 papers, and over 20 patent applications. She is the co-founder and member of the Scientific Advisory Board of LayerBio, Inc. and a member of the Scientific Advisory Board of Moderna Therapeutics.